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Ethnopharmacological  relevance:  Strychnos  pseudoquina  St. Hil.  (Loganiaceae)  is one  Brazilian  native
medicinal  species  described  in the  ﬁrst  edition  of  the  Brazilian  Ofﬁcial  Pharmacopoeia  in  1929. This
medicinal  plant,  popularly  known  as “quina-quina”,  “quina-branca”  or “casca  aromatica  was  very  com-
monly  used  in folk  medicine  in  tea  form  obtained  from  the  bark  and/or  leaves  as  tonic, antipyretic,
antimalarial  and mainly  against  diseases  of the  liver,  spleen  and  stomach.
Aim  of the  study:  Previous  study  already  characterized  the  gastroprotective  action  of this  species  The  aim  of
the  present  study  is  to elucidate  the  mechanism  of  the  healing  process  mediated  by  the  methanolic  extract
(ME)  and  their  enriched  alkaloid  fraction  (EAF)  from  Strychnos  pseudoquina  in  chronic  gastric  ulceration
induced  by  5% acetic  acid  in  rats,  an  experimental  model  that  accurately  reﬂects  human  gastrointestinal
disease.
Material  and methods:  The  ME  and  EAF  was  administered  orally  in a single  dose  (based  on  previously
study  of dose–response  curve)  for  14 days  after  chronic  ulceration  was  induced  in rats.  The  healing  effect
of ME  and  EAF  was  evaluated  by  macroscopic  and  morphometric  analyses,  immunohistochemical  assay
(PCNA  and SOD)  and  anti-Helicobacter  pylori  effect  was  evaluated  by in vitro  assay.
Results:  Our  results  demonstrated  that  EAF  signiﬁcantly  reduced  border  internal  (42%)  and  external  (38%)
lesion area  (mm2) by  macroscopic  analyses  (P  < 0.05).  Animals  treated  with  EAF  stimulated  some  prolifer-
ative  factors  by increasing  the  height  of  epithelial  regenerative  area  and  the  expression  of  PCNA-positive
nuclei.  The  number  of  vessels  in  gastric  mucosa  of rats  treated  with  EAF  reveals  an  expressive  increase
(4  times  more  than  vehicle  treatment)  of  vessels  that stimulate  cells  proliferation  in the  healing  region.
These  results  suggest  that  the  recovery  of vascularization  of  the  ulcerated  area is  involved  in  the heal-
ing  action  of alkaloid  fraction  of  Strychnos  pseudoquina.  The  MIC (minimum  inhibitory  concentration)  of
75 g/ml  from  EAF  showed  an  effective  in  vitro  anti-Helicobacter  pylori  action  of  this  fraction.  EAF  also
was  quite  effective  in  the  process  of SOD  release  that  is an  important  protective  factor  against  bacterial
agents.  The  efﬁcacy  of  EAF  was  accomplished  safely  without  presenting  any  alteration  of  toxicological
parameters  during  14  day  of treatment.
Conclusions:  The  expressive  gastric  healing  effect  by  increasing  cellular  proliferation  together  with  expres-
sion of  SOD  activity  and  antibacterial  action  against  Helicobacter  pylori  conﬁrm  the efﬁcacy  of  this  species
in heal  gastric  mucosa  and  these  results  are  a  important  contribution  to the knowledge  of a crude  drug
presents  at the  Brazilian  Ofﬁcial  Pharmacopoeia  since  1929.∗ Corresponding author. Tel.: +55 01438116077; fax: +55 1438153744.
E-mail address: hiruma@ibb.unesp.br (C.A. Hiruma-Lima).
378-8741 ©  2011 Elsevier Ireland Ltd. 
oi:10.1016/j.jep.2011.08.020
Open access under the Elsevier OA license. © 2011 Elsevier Ireland Ltd. 
1. Introduction
The genus Strychnos includes more than 200 species distributed
Open access under the Elsevier OA license. among tropical areas of the globe (Philippe et al., 2004). Many of
these species are known by their medicinal properties and for the
powerful toxicity character among their phytocompounds, such as
strychnine, one of the poisonous alkaloids produced by the species
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rom this genus (Thongphasuk et al., 2003). Among the medicinal
pecies, a folk medicine from Cerrado region of Brazil, there is the
pecies named Strychnos pseudoquina St. Hil known popularly as
quina-quina”, “quina-branca” or “casca aromatica”. This plant was
ery commonly used in folk medicine in tea form obtained from the
ark and/or leaves as tonic, antipyretic, antimalarial and mainly
gainst diseases of the liver, spleen and stomach (Pott and Pott,
994; Almeida et al., 1998; Lorenzi and Matos, 2002; Andrade-
eto et al., 2003). This medicinal plant was one of the Brazilian
ative species described in the ﬁrst edition of the Brazilian Ofﬁ-
ial Pharmacopoeia in 1929 as intermittent fevers, liver and spleen
isorders and as digestive (Brandão et al., 2008) but even eighty
ears afterwards few pharmacological studies have been devel-
ped with this species. Andrade-Neto et al. (2003) showed that
rude ethanol extract from the bark of this species presents weak
ntiplasmodial activity. Honório-Franc¸ a et al. (2008) demonstrated
hat aqueous extract from Strychnos pseudoquina bark provides
ypoglycemic action but did not heal wounds in diabetic rats. Silva
t al. (2005) showed the protective action of methanolic extract
ME) and enriched alkaloid fraction (EAF) from leaves of Strychnos
seudoquina to the gastric mucosa against injurious agents such
s non-steroidal anti-inﬂammatory drugs (NSAID) and an ethanol
cidiﬁed solution in mice. The same authors also observed that an in
ivo assay of ME  and EAF presented no toxic effects and no mortal-
ty for 14 days. However, studies from Santos et al. (2006) showed
hat ME  from Strychnos pseudoquina was mutagenic against strains
f Salmonella,  but the EAF presented absence of mutagenicity in this
ame assay.
The conﬁrmation of gastroprotective action of ME  and EAF from
trychnos pseudoquina by Silva et al. (2005) is an important indica-
ive of antiulcer property of this species, corroborating its reputed
tility in folk medicine that mainly obtained polar compounds as
ea form. However, these actions do not imply that these same
reparations also present ulcer healing effect on injured gastric
ucosa. So the aim of this study was to evaluate the healing action
f ME  or EAF of Strychnos pseudoquina throughout 14 consecutive
ays in the chronic ulcer model induced by acetic acid in rats. We
lso evaluated some toxicological parameters by subacute treat-
ents with Strychnos pseudoquina and the anti-Helicobacter pylori
ction of this species.
. Materials and methods
.1. Plant material and extraction of ME  and EAF
Leaves of Strychnos pseudoquina St. Hil. were collected in
ay  2001 from Porto Nacional city, Tocantins State, Brazil and
dentiﬁed by Prof. E.R. Santos, from the Institute of Biology at
ocantins University. A herbarium specimen voucher (Nr. 3291)
as deposited at the Herbarium of Tocantins University (HTINS).
he leaves were air-dried and powdered in a mill. Leaves of
trychnos pseudoquina (300 g) were extracted in powder form
ith methanol as solvent during seven days. Solvent was evap-
rated in a vacuum to yield 17.7 g of extract (ME) (3:10 was  the
lant:solvent ration). A portion (5.0 g) of the methanolic extract
MeOH) of Strychnos pseudoquina was submitted to column chro-
atography on Sephadex LH-20 (100 cm × 5 cm)  with MeOH as
he eluent. One hundred fractions (5 ml)  were collected, checked
y TLC on silica gel plates CHCl3–MeOH–n-PrOH–H2O (5:6:1:4,
/v/v/v lower phase) and revealed with Draggendorff, iodoplati-
ate or NP/PEG (Natural Products/Polyethyleneglycol) reagents.
lkaloids were detected in Fr. 3–29 (denominated “enriched alka-
oid fraction—EAF 3 g) and ﬂavonoids were detected in Fr. 35–90
250 mg). These exactly the same batches from MeOH and the
AF have been used in this study were extensively study andarmacology 138 (2011) 47– 52
phytochemical proﬁles of both were described by Silva et al.
(2005).
2.2. Animals
Male Wistar albino rats (150–250 g) from the Central Animal
House of the UNESP were used. The animals were fed a certiﬁed
Nuvilab® (Nuvital) diet with free access to tap water under standard
conditions of 12 h dark-12 h light, humidity (60 ± 1.0%) and temper-
ature (21 ± 1 ◦C). Fasting (24 h) was used prior to assays because
standard drugs, ME  or EAF were always administered by orally
using a saline solution (10 ml/kg) as vehicle. Animals were kept
in cages with raised ﬂoors of wide mesh to prevent coprophagy.
All experiments were performed in the morning, and followed the
recommendations of the Canadian Council on Animal Care (Olfert
et al., 1993). The UNESP Institution for Animal Care approved the
employed protocols.
2.3. Healing in acetic acid-induced gastric lesion
The experiment was  performed according to the method
described by Takagi et al. (1969), with some modiﬁcations. Three
groups of rats that had fasted for 24 h were used in this exper-
iment (n = 7–8). Under anesthesia, a laparotomy was performed
on all animals through a midline epigastric incision. After expos-
ing the stomach, 0.05 ml  (v/v) of a 30% acetic acid solution was
injected into the subserosal layer in the glandular part of the ante-
rior wall. The stomach was  bathed with saline (20 ◦C) to avoid
adherence to the external surface of the ulcerated region. The
abdomen was  then closed and all the animals were fed normally.
We selected the lowest effective dose of ME  or EAF (250 mg/kg
body wt.) to evaluate the healing effect of Strychnos pseudoquina
based on data from Silva et al. (2005) that evaluated the gas-
troprotective action of ME  or EAF on acute gastric lesion model.
The other group was treated with 100 mg/kg of pure cimetidine
(Sigma Co., USA) or vehicle (10 ml/kg) to determine healing effects
by subacute treatment. All treatments were administered orally
once a day for 14 consecutive days beginning one day after surgery.
Body weight was recorded daily throughout the experiments and
the macroscopic analyses and weights of vital organs (liver, kid-
ney, heart, spleen and lung) were compared among the different
treatments and the group treated with vehicle to evaluate the pos-
sible subacute toxicity induced by ME  or EAF. On the day after
the last drug administration, the rats were killed and their stom-
achs were gently removed. The gastric lesions were evaluated by
examining the inner gastric surface with a dissecting magnifying
glass. The macroscopic ulcer area of the internal border and exter-
nal border (mm2) were determined as described by Takagi et al.
(1969).
2.3.1. Histological methods
The stomach lesions induced by acetic acid in rats submit-
ted to the different treatments were located, sectioned, and ﬁxed
in ALFAC solution (70% ethanol, 4% formaldehyde and 5% glacial
acetic acid) for 24 h at 4 ◦C. Then the samples were routinely
processed for embedding in paraplast, and cut into 7 m-thick sec-
tions that were strained with periodic acid–Schiff (PAS) (Vacca,
1985) and hematoxylin-eosin (HE) (Behmer et al., 1976). Parafﬁn
slides were processed for HE straining and imunohistochemical
reaction in blood vessels. For both analyses, we  used at least 6
ﬁelds for each group and the results were submitted to statistical
analyses.2.3.2. Morphometric analyses
For the morphometric analyses a slice of stomach was exam-
ined in a Leica microscope coupled with Leica Qwin Software (Leica,
F. Bonamin et al. / Journal of Ethnopharmacology 138 (2011) 47– 52 49
Table 1
Regeneration measures of the gastric lesion borders (epithelial height) and the new blood vessels in the regeneration areas under the mucous membrane in histological
analysis of the stomach treated with EAF of Strychnos pseudoquina under the model of ulcer induction by acetic acid.
Treatments (p.o.) Doses (mg/kg) Epithelial height (m) Number of new blood vessels (m2)
Saline – 1462.00 ± 25.27 178.01 ± 20.64
Cimetidine 100 1489.50 ± 17.56 309.17 ± 30.33*
EAF 250 1611.70 ± 28.14** 633.95 ± 33.97**
Results are mean ± S.E.M. Statistical analysis among the groups: ANOVA following by Dun
* P < 0.05.
** P < 0.01.
Fig. 1. Inﬂuence of ulcer healing activity of methanolic extract (ME  = 250 mg/kg)
and alkaloids fraction (EAF = 250 mg/kg) of the Strychnos pseudoquina in acetic acid-
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accelerated the lesion-healing effect (Pawlik et al., 2002). Based on
F
tnduced gastric lesion. Data from black bars represents internal border and gray bars
epresents external border from lesion.
ngland), where the height of regenerated mucosa was  measured
y employing a variation of the method used by Ishihara and Ito
2002).
.3.3. Immunohistochemical analyses
The antibodies utilized (Novo Castra NCL-PCNA) included anti-
CNA (cell division marker, to evaluate regeneration potential) and
nti-SOD (superoxide dismutase, to evaluate antioxidant activity
n the superoxide radicals). Slices were deparafﬁnized, dehy-
rated and immunostrained with peroxidase by the avidin–biotin
ethod. High temperature antigen unmasking technique in 0.01 M
itrate buffer, pH 6, in a microwave oven was  performed two
imes for 5 min  total. Blocking of nonspeciﬁc reaction was com-
leted with 1% normal goat serum and 3% not-fat milk. After
ising in phosphate buffered saline (0.01 mol/L PBS pH 7.4), the
ections were incubated in secondary antiserum. They were then
ashed in PBS and incubated in ABC (avidine and biotine complex)
eagents (ABC kit—Vector) and incubated in peroxidase reac-
ion (3,3′-diaminobenzidine tetrahydrochoride containing 0.01%
2O2 in PBS buffer. After being immunostrained, the sections
ere lightly counterstained with Mayer’s hematoxylin. The slides
ere observed under a Leica light microscope. For positive con-rol we used the stem cell region in stomach mucosa and for
egative control the primary and secondary antibodies were
mitted.
ig. 2. Histological analysis of the stomachs of rats treated with saline, cimetidine and Str
he  area used as morphometric parameter (height) of the regeneration area (#) in gastricnett’s test.
2.4. Anti-Helicobacter pylori activity
The ME  and EAF were tested to detect anti-Helicobacter pylori
activity (Hachem et al., 1996). The strain of Helicobacter pylori
(ATCC 43504) was isolated from patients with duodenal ulcer dis-
ease. Frozen Helicobacter pylori isolate was  thawed and grown on
5% sheep blood agar plates for 3–4 days at 37 ◦C in 10% CO2 and
98% humidity. Each plate was  swabbed with a sterile cotton-tipped
applicator and the cells were suspended in sterile saline to obtain
turbidity equivalent to a 2.0 McFarland standard. Muller–Hinton
broth containing 10% horse serum was added to all wells of a 96-
well microtiter plate (Corning, USA). Each well was incubated with
Helicobacter pylori at a ﬁnal concentration of ∼1 × 105 CFU/ml. The
plates were incubated for 5 days in a microaerobic atmosphere
at 37 ◦C. Following incubation, the plates were examined visually
and spectrophotometrically and the lowest concentration showing
complete inhibition of growth was recorded as the MIC (minimum
inhibitory concentration). Staphylococcus aureus (ATCC 25923) and
Escherichia coli (ATCC 25922) were used as control organisms for
clarithromycin and ampicillin, respectively. The results were con-
sidered valid only when the MIC  values for the control organisms
were within the ranges established by the National Committee for
Clinical Laboratory Standards (NCCLS).
2.5. Statistical analysis
Results were expressed as mean ± S.E.M. Statistical signiﬁcance
was determined by one-way analysis of variance followed by Dun-
nett’s or Tukey’s test, with the signiﬁcance level at P < 0.05.
3. Results and discussion
Since the gastric ulcer model induced by acetic acid was estab-
lished more than 40 years ago (Takagi et al., 1969) this assay has
been used for the study of underlying mechanisms of ulcer cicatri-
sation by subacute and chronic treatment of anti-ulcer drugs thatdata from Okabe and Agamase (2005),  this model was  the one that
most closely approximates human peptic ulcer disease, because the
damage caused by the acetic acid penetrates in gastric mucosa not
ychnos pseudoquina (ME  and EAF) during 14 consecutive days. The arrows indicate
 lesions caused by acetic acid in rats. Microscopy magniﬁcation 2.5×.
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nly in the mucous membrane and submucous layer but also the
uscular layer.
Fig. 1 shows the result of the macroscopic analysis of the gas-
ric lesions induced by acetic acid in rats treated with vehicle,
imetidine, ME  or EAF from Strychnos pseudoquina. Our results
hown that although ME  from Strychnos pseudoquina induced sig-
iﬁcant gastroprotective effect against injuries caused by NSAID
nd ethanol/HCl in mice (Silva et al., 2005), the treatment of rats
or 14 consecutive days with this extract did not reveal signiﬁcant
ealing action by reducing internal or external border area, when
ompared macroscopically with vehicle-treated animals (P > 0.05).
owever, the gastric lesions of the animals treated with EAF, at
he same dose, induced signiﬁcant reduction (P < 0.05) in internal
42%) and external (38%) border. This macroscopic result was also
roven by histological analyses (Table 1) in which the height of
he regeneration area (m)  was measured. The animals treat with
AF from Strychnos pseudoquina signiﬁcantly increased epithelial
eight in regenerative area of gastric mucosa when compared with
ehicle-treated ones. These results suggested EAF stimulated some
roliferative factors in gastric mucosa that were important factors
o regeneration of injured gastric mucosa.
Wallace and Devchand (2005) reported that reconstructing the
ntire structural architecture of gastric mucosa damage can require
everal weeks and involves the formation of granulation tissue at
he base of the ulcers, formation of new vessels (angiogenesis), and
e-establishment of the whole glandular architecture. The qual-
ty of mucosal structural restoration may  be the most important
actor in determining future ulcer recurrence (Tarnawski, 2005).
&E straining of histological cuts (Fig. 2) from EAF-treated animals
eveals well structured mucous glands in the highly regenerated
rea that probably provoked their elongation and alignment. The
rchitectural reorganization of regenerated area in EAF-treated ani-
als (Fig. 2) facilitates the passage of the mucus and of other
ubstances towards the surface of the gastric mucous membrane.
arnawski et al. (1991) indicated that some gastric mucosa showed
e-epithelialization of the mucosal surface but that subepithelial
ucosa displayed prominent abnormalities. These abnormalities
ould interfere with oxygenation, nutrient supply, and mucosal
esistance and defense; therefore, they could be a basis for ulcer
ecurrence.
Cellular proliferation plays an important role in maintaining
he integrity of the gastrointestinal system. Cell division in gas-
rointestinal treatment is limited to a discreet anatomical area,
he proliferative compartment (Okamoto and Watanabe, 2004). To
nvestigate the effect of EAF on cell proliferation in the gastric ulcer
rea, this parameter was determined by immunohistochemical
ssay (Fig. 3). In the vehicle group, the immunoreactions for PCNA
expressed throughout the cell cycle whereas its concentration
ncreased further in the S-phase) were observed as dark accumu-
ations of DAB (diaminobenzidine) reaction products in the nuclei
f the gastric mucosa layer. We  observed that the EAF-ulcerated
roup stimulated the cell proliferation in the regeneration area,
ainly at the base of the mucous glands (Fig. 3). So PCNA-positive
uclei from EAF-group was incontestably more intense than in the
ehicle-treated or the cimetidine positive control group.
Previous studies also suggested that the quality of epithelial sur-
ace reconstitution was guaranteed by angiogenesis (formation of
 new vascular network) that ensures an adequate supply of oxy-
en and nutrients to the healing mucosa (Tarnawski et al., 2001;
arnawski, 2005). We  quantiﬁed vessels in gastric mucosa sub-
itted to different treatments (Table 1). The number of vessels in
ats treated with cimetidine was double that in those treated only
ith vehicle. But the number of vessels in gastric mucosa of rats
reated with EAF from Strychnos pseudoquina reveals an expres-
ive increase (4 times more than vehicle treatment) of vessels. This
esult indicates that EAF treatment induced healing action in gastric Ta
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tig. 3. Coloration immunohistochemistry for PCNA in stomachs of rats treated with
rganization of the mucous membrane (EAF) is with a lot of cells positive PCNA (br
he  references to color in this ﬁgure legend, the reader is referred to the web  versio
ucosa by proliferating vessels in gastric mucosa that stimulated
ell proliferation in the healing region.
Leite et al. (2004) observed that replenishment of SOD (super-
xide dismutase) led to decrease in constrictive remodeling and
nhanced angiogenesis. SOD is the most important enzymes
esponsible for eliminating free radicals from the cell, given that
t transforms O2•− radicals into H2O2 and protects the cells from
amage through the removal of those radicals. The SOD activity
evel represents the intracellular antioxidant ability of the cell. The
ree radicals affect the structure of the cell membrane as well as
he membranes of various organelles including the mitochondria,
ysosomes and the endoplasmic reticulum (Wang et al., 2005).
The participation of SOD in the EAF action mechanism was also
valuated, due to its importance as an antioxidant and elimina-
or of free radicals from the cells (Wang et al., 2005; Fan et al.,
005). The result of this study evidenced a greater number of
trained cells (in brown) from the EAF-treated group than in groups
reated with vehicle (Fig. 4). We  also observed that SOD strained
ells were not present in cimetidine-treated group. Konturek et al.
2000) observed that SOD accelerates the healing of ischemia and
eperfusion lesions due to suppression of oxygen free radicals and
mprovement of gastric microcirculation. Based on our result we
oncluded that the EAF is quite effective in the process of releasing
OD, eliminating free radicals and, thus, healing gastric lesions.
Some new antiulcer drugs, such as rebamipide, were effective
n inducing ulcer healing but failed in Helicobacter pylori erad-
cation therapy (Terano et al., 2007). As it is highly desirable
o identify one drug that produces gastroprotective action, heals
njured gastric mucosa and also acts against Helicobacter pylori,  we
valuated the anti-Helicobacter pylori effect of EAF from Strych-
os pseudoquina against a strain of Helicobacter pylori isolated
rom patients with duodenal ulcer disease. Recently, Castillo-Juárez
t al. (2009) evaluated plants used in traditional medicine against
elicobacter pylori while considering an MIC  value lower than
ig. 4. Coloration immunohistochemistry for SOD in stomachs of rats treated with saline
rganization of the mucous membrane (EAF) is with a lot of cells positive SOD (brown c
he  references to color in this ﬁgure legend, the reader is referred to the web  version of th, cimetidine (100 mg/kg) and Strychnos pseudoquina (EAF). (→) The area of reverse-
olor, suitable for the arrow). Microscopy magniﬁcation 20×.  (For interpretation of
e article.)
125 g/ml, to constitute strong antibacterial action. We  obtained
a very interesting MIC  from EAF of 75 g/ml, a ﬁnding that indi-
cates a highly satisfactory anti-Helicobacter pylori action from this
fraction.
Over twenty years ago Garner (1986) predicted that the future
of antiulcer drug research must address the multifactorial eti-
ologies of gastric ulcer as well as attempt to cure the disease
rather than simply induce antisecretory action. But the efﬁcacy
of the new drug must also be accompanied by a clear indica-
tion for safe human use. Silva et al. (2005) observed that EAF
and ME  from Strychnos pseudoquina did not present acute tox-
icity given that no mortality was observed up to 5 g/kg (p.o.).
Animals submitted to different treatments (EAF, ME,  cimeti-
dine and vehicle) in gastric ulcer model induced by acetic acid
supply some important toxicity parameters such as evolution
of body weight during 14 days(data not show), mortality, and
weight of the vital organs (Table 2). The 14-day evolution in
body weight alteration under EAF did not differ signiﬁcantly
from the vehicle group while the average weights of vital organs
and visceral conditions were normal and comparable to those
of the control group (P > 0.05). The ﬁnding of one death regis-
tered in each of the saline, cimetidine and EAF groups, does not
necessarily represent a toxicity sign but rather a consequence
of the surgical procedure of this model. Table 2 also presents
results obtained by biochemical analyses of serum, organized by
treatments, among which we observed no alteration of these
parameters.
Santos et al. (2006) described that mutagenic effect of methano-
lic extract from Strychnos pseudoquina present in Ames and
micronucleus tests. But they also recommend that EAF from
Strychnos pseudoquina should be explored as a possible source
of new antiulcerogenic phytotherapeutic preparation because the
absences of mutagenicity but new toxicological studies are neces-
sary to ensure its safety use in human.
, cimetidine (100 mg/kg) and Strychnos pseudoquina (EAF). (→) The area of reverse-
olor, suitable for the arrow). Microscopy magniﬁcation 20×. (For interpretation of
e article.)
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Phytochemical studies of EAF, in agreement with Silva et al.
2005), yielded nordiidroﬂuorcurarine, an alkaloid indole, in addi-
ion to rutin and kaempferol 3-O--rutenoside. The structure of
ndolic alkaloid 3-hydroxy-enolate resembles that of omeprazole,
 well known antiulcer agent. However, this alkaloid may  possess
 reversible bond between sulfhydryl groups and does not present
dverse side effects from omeprazole related to carcinoma.
. Conclusions
Based on the results of the present work we concluded that the
AF from Strychnos pseudoquina presents expressive healing effect
n gastric mucosa through the increase of angiogenesis, cell pro-
iferation, antioxidant activity through expression of SOD activity
nd antibacterial action against Helicobacter pylori. The absence of
oxicity throughout the 14 consecutive days of treatment ensures
ts safety for use by the population.
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